Ceptur Therapeutics Funding: $75M Raised, Series A (2022)
Ceptur Therapeutics is based in Hillsborough, NJ. It has raised $75M in total funding. Latest round: Series A.
Ceptur Therapeutics funding overview
Ceptur Therapeutics is based in Hillsborough, NJ. Ceptur Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for Ceptur Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include venBio Partners, Qiming Venture Partners USA, Bristol Myers Squibb, Perceptive Xontogeny Venture (PXV) Fund, Janus Henderson Investors, Affinity Asset Advisors and 2 others. 8 distinct backers are named across the disclosed rounds.
Frequently asked about Ceptur Therapeutics funding
How much has Ceptur Therapeutics raised?
Ceptur Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Ceptur Therapeutics?
venBio Partners, Qiming Venture Partners USA, Bristol Myers Squibb, Perceptive Xontogeny Venture (PXV) Fund, Janus Henderson Investors, Affinity Asset Advisors are named among the investors backing Ceptur Therapeutics.
What was the latest Ceptur Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2022.
Where is Ceptur Therapeutics based?
Ceptur Therapeutics is based in Hillsborough, NJ.
When did Ceptur Therapeutics last raise?
The last disclosed Ceptur Therapeutics round closed in January 2022 at Series A.
We update the Ceptur Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hillsborough and their backers are listed below.
